Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)

SHE:301111 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	372.32	143.14	159.1	131.11	179.21	485.35
Short-Term Investments	-	29.29	128.25	141.14	190.97	20.42
Trading Asset Securities	62.4	77.59	34.81	72.86	81.32	48.04
Cash & Short-Term Investments	434.73	250.01	322.16	345.11	451.51	553.81
Cash Growth	29.46%	-22.39%	-6.65%	-23.57%	-18.47%	312.00%
Accounts Receivable	116.14	97.42	85.23	74	71.01	97.57
Other Receivables	4.15	2.92	2.69	3.34	2.01	1.94
Receivables	120.29	100.35	87.91	77.34	73.02	99.51
Inventory	75.88	77.31	90.13	83.43	70.69	51.91
Prepaid Expenses	-	-	0	-	-	-
Other Current Assets	94.27	273.23	14.99	3.78	5.73	3.62
Total Current Assets	725.17	700.9	515.2	509.66	600.95	708.84
Property, Plant & Equipment	79.1	83.51	115.24	58.59	55.94	74.55
Long-Term Investments	28.9	42.5	219.41	238.08	181.28	33.47
Goodwill	7.32	7.32	7.32	-	-	-
Other Intangible Assets	29.05	29.52	29.88	30.18	7.83	7.89
Long-Term Deferred Tax Assets	12.46	13.81	13.91	8.51	8.52	1.22
Long-Term Deferred Charges	15.01	15.79	28.71	0.4	-	-
Other Long-Term Assets	10.88	0.76	3.49	10.13	2.56	0.23
Total Assets	907.89	894.13	933.17	855.54	857.07	826.2

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	70.64	63.72	56	34.87	29.04	37.59
Accrued Expenses	5.49	12.19	12.71	11.4	17.25	9.38
Current Portion of Leases	-	5.24	1.29	3.87	0.16	0.93
Current Income Taxes Payable	6.09	0.01	1.29	0.2	9.85	5.09
Current Unearned Revenue	18.34	13.49	12.44	5.39	26.88	5.66
Other Current Liabilities	8.38	7.62	11.13	10.24	10.19	7.44
Total Current Liabilities	116.41	102.28	94.85	65.97	93.36	66.08
Long-Term Leases	36.36	40.24	70.86	10.09	-	0.16
Long-Term Unearned Revenue	0.27	0.39	0.7	1.28	5.04	7.45
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.66
Total Liabilities	153.04	142.91	166.42	77.33	98.39	75.34

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	160	160	160	160	160	160
Additional Paid-In Capital	405.78	405.78	406.94	406.94	406.94	406.94
Retained Earnings	180.1	184.91	197.4	209.23	191.73	183.91
Total Common Equity	745.88	750.69	764.34	776.17	758.67	750.85
Minority Interest	8.96	0.53	2.41	2.03	-0	-
Shareholders' Equity	754.84	751.22	766.75	778.21	758.67	750.85
Total Liabilities & Equity	907.89	894.13	933.17	855.54	857.07	826.2

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	43.83	45.49	72.15	13.95	0.16	1.09
Net Cash (Debt)	390.9	204.53	250.01	331.15	451.35	552.72
Net Cash Growth	50.51%	-18.19%	-24.50%	-26.63%	-18.34%	311.19%
Net Cash Per Share	2.56	1.37	1.80	2.08	2.84	4.64
Filing Date Shares Outstanding	160.83	160	160	160	160	160
Total Common Shares Outstanding	160.83	160	160	160	160	160
Working Capital	608.75	598.63	420.34	443.69	507.59	642.77
Book Value Per Share	4.64	4.69	4.78	4.85	4.74	4.69
Tangible Book Value	709.51	713.85	727.13	745.99	750.85	742.96
Tangible Book Value Per Share	4.41	4.46	4.54	4.66	4.69	4.64
Buildings	-	75.12	76.38	68.76	74.73	79.72
Machinery	-	89.54	86.7	78.07	78.59	93.14
Construction In Progress	-	-	-	0.72	0.72	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error